Cargando…
Antiviral Efficacy of RNase H-Dependent Gapmer Antisense Oligonucleotides against Japanese Encephalitis Virus
RNase H-dependent gapmer antisense oligonucleotides (ASOs) are a promising therapeutic approach via sequence-specific binding to and degrading target RNAs. However, the efficacy and mechanism of antiviral gapmer ASOs have remained unclear. Here, we investigated the inhibitory effects of gapmer ASOs...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573891/ https://www.ncbi.nlm.nih.gov/pubmed/37834294 http://dx.doi.org/10.3390/ijms241914846 |
_version_ | 1785120566420701184 |
---|---|
author | Okamoto, Shunsuke Echigoya, Yusuke Tago, Ayaka Segawa, Takao Sato, Yukita Itou, Takuya |
author_facet | Okamoto, Shunsuke Echigoya, Yusuke Tago, Ayaka Segawa, Takao Sato, Yukita Itou, Takuya |
author_sort | Okamoto, Shunsuke |
collection | PubMed |
description | RNase H-dependent gapmer antisense oligonucleotides (ASOs) are a promising therapeutic approach via sequence-specific binding to and degrading target RNAs. However, the efficacy and mechanism of antiviral gapmer ASOs have remained unclear. Here, we investigated the inhibitory effects of gapmer ASOs containing locked nucleic acids (LNA gapmers) on proliferating a mosquito-borne flavivirus, Japanese encephalitis virus (JEV), with high mortality. We designed several LNA gapmers targeting the 3′ untranslated region of JEV genomic RNAs. In vitro screening by plaque assay using Vero cells revealed that LNA gapmers targeting a stem-loop region effectively inhibit JEV proliferation. Cell-based and RNA cleavage assays using mismatched LNA gapmers exhibited an underlying mechanism where the inhibition of viral production results from JEV RNA degradation by LNA gapmers in a sequence- and modification-dependent manner. Encouragingly, LNA gapmers potently inhibited the proliferation of five JEV strains of predominant genotypes I and III in human neuroblastoma cells without apparent cytotoxicity. Database searching showed a low possibility of off-target binding of our LNA gapmers to human RNAs. The target viral RNA sequence conservation observed here highlighted their broad-spectrum antiviral potential against different JEV genotypes/strains. This work will facilitate the development of an antiviral LNA gapmer therapy for JEV and other flavivirus infections. |
format | Online Article Text |
id | pubmed-10573891 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-105738912023-10-14 Antiviral Efficacy of RNase H-Dependent Gapmer Antisense Oligonucleotides against Japanese Encephalitis Virus Okamoto, Shunsuke Echigoya, Yusuke Tago, Ayaka Segawa, Takao Sato, Yukita Itou, Takuya Int J Mol Sci Article RNase H-dependent gapmer antisense oligonucleotides (ASOs) are a promising therapeutic approach via sequence-specific binding to and degrading target RNAs. However, the efficacy and mechanism of antiviral gapmer ASOs have remained unclear. Here, we investigated the inhibitory effects of gapmer ASOs containing locked nucleic acids (LNA gapmers) on proliferating a mosquito-borne flavivirus, Japanese encephalitis virus (JEV), with high mortality. We designed several LNA gapmers targeting the 3′ untranslated region of JEV genomic RNAs. In vitro screening by plaque assay using Vero cells revealed that LNA gapmers targeting a stem-loop region effectively inhibit JEV proliferation. Cell-based and RNA cleavage assays using mismatched LNA gapmers exhibited an underlying mechanism where the inhibition of viral production results from JEV RNA degradation by LNA gapmers in a sequence- and modification-dependent manner. Encouragingly, LNA gapmers potently inhibited the proliferation of five JEV strains of predominant genotypes I and III in human neuroblastoma cells without apparent cytotoxicity. Database searching showed a low possibility of off-target binding of our LNA gapmers to human RNAs. The target viral RNA sequence conservation observed here highlighted their broad-spectrum antiviral potential against different JEV genotypes/strains. This work will facilitate the development of an antiviral LNA gapmer therapy for JEV and other flavivirus infections. MDPI 2023-10-02 /pmc/articles/PMC10573891/ /pubmed/37834294 http://dx.doi.org/10.3390/ijms241914846 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Okamoto, Shunsuke Echigoya, Yusuke Tago, Ayaka Segawa, Takao Sato, Yukita Itou, Takuya Antiviral Efficacy of RNase H-Dependent Gapmer Antisense Oligonucleotides against Japanese Encephalitis Virus |
title | Antiviral Efficacy of RNase H-Dependent Gapmer Antisense Oligonucleotides against Japanese Encephalitis Virus |
title_full | Antiviral Efficacy of RNase H-Dependent Gapmer Antisense Oligonucleotides against Japanese Encephalitis Virus |
title_fullStr | Antiviral Efficacy of RNase H-Dependent Gapmer Antisense Oligonucleotides against Japanese Encephalitis Virus |
title_full_unstemmed | Antiviral Efficacy of RNase H-Dependent Gapmer Antisense Oligonucleotides against Japanese Encephalitis Virus |
title_short | Antiviral Efficacy of RNase H-Dependent Gapmer Antisense Oligonucleotides against Japanese Encephalitis Virus |
title_sort | antiviral efficacy of rnase h-dependent gapmer antisense oligonucleotides against japanese encephalitis virus |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573891/ https://www.ncbi.nlm.nih.gov/pubmed/37834294 http://dx.doi.org/10.3390/ijms241914846 |
work_keys_str_mv | AT okamotoshunsuke antiviralefficacyofrnasehdependentgapmerantisenseoligonucleotidesagainstjapaneseencephalitisvirus AT echigoyayusuke antiviralefficacyofrnasehdependentgapmerantisenseoligonucleotidesagainstjapaneseencephalitisvirus AT tagoayaka antiviralefficacyofrnasehdependentgapmerantisenseoligonucleotidesagainstjapaneseencephalitisvirus AT segawatakao antiviralefficacyofrnasehdependentgapmerantisenseoligonucleotidesagainstjapaneseencephalitisvirus AT satoyukita antiviralefficacyofrnasehdependentgapmerantisenseoligonucleotidesagainstjapaneseencephalitisvirus AT itoutakuya antiviralefficacyofrnasehdependentgapmerantisenseoligonucleotidesagainstjapaneseencephalitisvirus |